OUR PRODUCTS

MOBILE APPS

GENERAL INFO

BBIO

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

BridgeBio Pharma (BBIO) Earnings Date & Reports

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BBIO is expected to report earnings to fall 14.18% to -81 cents per share on October 30

BridgeBio Pharma BBIO Stock Earnings Reports

Q3'25

Est.

$-0.82

Q2'25

Missed

by $0.20

Q1'25

Beat

by $0.03

Q4'24

Missed

by $0.27

Q3'24

Beat

by $0.13

The last earnings report on August 05 showed earnings per share of -94 cents, missing the estimate of -75 cents. With 2.96M shares outstanding, the current market capitalization sits at 10.05B.

View a ticker or compare two or three

Compare

BBIO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For BBIO
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BBIO showed earnings on August 05, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a company which engages in developing transformative medicines to treat patients who suffer from mendelian diseases.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

3160 Porter Drive

Phone

+1 650 391-9740

Employees

556

Web

https://www.bridgebio.com